Indefinite Delivery Contract 75F40118D10028

The summary is as follows:

The Department of Health and Human Services' Food and Drug Administration (FDA) has awarded an Indefinite Delivery Contract (IDC) worth up to $10 million to Molecular Epidemiology Inc., a for-profit, woman-owned small business. The contract is for microbiological analysis of FDA-regulated foods, agricultural water, and cosmetics. This includes tasks such as whole genome sequencing, pathogen testing, and epidemiological assessments to support the FDA's food safety and public health missions. Multiple task orders have already been issued under this IDC, valued from approximately $50,000 to over $1 million, for projects involving sample collection and analysis of products like shrimp, lettuce, infant formula, and agricultural soil/water. Molecular Epidemiology Inc. also holds a separate $750,000 IDIQ contract with the FDA for general sampling and analysis services. These contracts demonstrate the FDA's ongoing reliance on the company's expertise in detecting and tracking foodborne contaminants and pathogens.

The original solicitation was for a request for proposals (RFP) to provide microbial analysis of FDA-regulated foods and cosmetics. The contracts are firm-fixed price with no set-aside designations. Work is primarily performed at the company's facilities in Washington and Maryland. These long-term, flexible IDIQ/IDC vehicles allow the FDA to efficiently task Molecular Epidemiology Inc. to provide critical testing and research as needed to support the agency's food safety monitoring and outbreak response efforts.